Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
ARCH VENTURE MANAGEMENT LLC | 02-14-2024 | 12-31-2023 | 7 | 163,507,430 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
EQRX, INC. | COM | Liquidated | $0 | 0 | 52.39 | 41.73 | 0 | 0.00 | 12-31-2023 |
REVOLUTION MEDICINES, INC. | COM | 2 | $92,736,493 | 3,233,490 | 0.06 | 3,233,490 | +Inf | 12-31-2023 | |
VERVE THERAPEUTICS, INC. | COM | 3 | $28,002,797 | 2,008,809 | 0.02 | 17.30 | 0 | 0.00 | 12-31-2023 |
ERASCA, INC. | COM | 4 | $23,548,330 | 11,055,554 | 0.01 | 14.15 | 0 | 0.00 | 12-31-2023 |